AMPHORA, the Alcohol Public Health Research Alliance is a four-year €4 million project co-financed by the Seventh Framework Programme (FP7) of the European Commission and coordinated by the Hospital Clínic de Barcelona (HCPB) in Spain.
AMPHORA aims to contribute with new evidence on scarcely explored and unexplored areas of alcohol consumption as well as alcohol-related harm in Europe. This knowledge will be disseminated to those engaged in policy-making for development and implementation of more effective public health measures.The AMPHORA scientists have developed a manifesto, presented during the European Debate on Evidence-based Alcohol Policy which took place in Stockholm, Sweden on 18th and 19th October. The Manifesto calls for strong and simple policy measures to tackle the European alcohol problem. Amongst a range of measures, the manifesto calls on governments to adopt the most cost-effective evidence-based policies, namely increasing price and reducing the availability of alcohol, together with banning all forms of alcohol advertising. The full manifesto can be accessed with the link below.
FACT: Europe has the highest per-capita alcohol consumption. In fact, it is estimated that each year 55 million Europeans drink at dangerous levels.
As a consequence, alcohol is the 3rd leading risk factor for death and disability in Europe, contributing to disease, injuries and accidents and harming European society and economy.
See the video below
For more information visit www.amphoraproject.net
The AMPHORA project will run until end 2012.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter